Goldman Sachs’s Telomir Pharmaceuticals TELO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$201K	Buy	160,594 +128,312	+397%	+$160K	﹤0.01%	4731
2025 Q1	$104K	Sell	32,282 -18,248	-36%	-$58.9K	﹤0.01%	4815
2024 Q4	$208K	Buy	+50,530	New	+$208K	﹤0.01%	4651